title: Alopecia Areata-Part III: Prognosis and Treatment.
abstract: The prognosis of alopecia areata is better in cases with single and small lesions, and the variability of the extension of the disease is one of the criteria for the choice of treatment modality. Several medications have been described in the literature for the treatment of alopecia areata, including corticosteroids, minoxidil, and diphencyprone. The authors review treatments for alopecia areata.
authors.affiliation: Sector of Dermatology and Post-Graduation Course, University Hospital and School of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.|Sector of Medical Genetics, Pediatric Institute Martagão Gesteira and School of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
authors.forename: Juliany
authors.initials: J
authors.lastname: Estefan
authors.affiliation: Sector of Medical Genetics, Pediatric Institute Martagão Gesteira and School of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
authors.forename: Marcia
authors.initials: M
authors.lastname: Ribeiro
authors.affiliation: Sector of Dermatology, Pediatric Institute Martagão Gesteira and School of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
authors.forename: Eliane
authors.initials: E
authors.lastname: Abad
authors.affiliation: Sector of Dermatology, Pediatric Institute Martagão Gesteira and School of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
authors.forename: Simone
authors.initials: S
authors.lastname: Saintive
authors.affiliation: Sector of Dermatology and Post-Graduation Course, University Hospital and School of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; ramos.e.silva@dermato.med.br.
authors.forename: Marcia
authors.initials: M
authors.lastname: Ramos-E-Silva
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000506:Alopecia Areata / Q000188:drug therapy* / Q000473:pathology; D003521:Cyclopropanes / Q000627:therapeutic use*; D006801:Humans; D008914:Minoxidil / Q000627:therapeutic use*; D011379:Prognosis; D014665:Vasodilator Agents / Q000627:therapeutic use*
chemical_list: D000305:Adrenal Cortex Hormones; D003521:Cyclopropanes; D014665:Vasodilator Agents; D008914:Minoxidil; C029402:diphenylcyclopropenone